ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2

ViroStatics is a privately held small pharmaceutical company dedicated to discovering and developing novel compounds for a multifaceted treatment of cancers and viral diseases and focuses on novel, selective, host cell kinase targeted inhibitors in its state-of-the-art Biological Safety Level 3 Laboratory. The company has strong expertise in testing drugs, natural substances, disinfectants, or any material for activity against SARS-CoV-2, either in liquid suspension or aerosol.